AEON Biopharma (AEON) vs Rocket One (RKTO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Rocket One (RKTO) has outperformed AEON Biopharma (AEON) over the past year, losing 59.1% versus a loss of 66.3%. Rocket One is the larger company by market cap ($16.4 million vs $14.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AEON | RKTO |
|---|---|---|
| Share price | $0.2837 | $0.6599 |
| Market cap | $14.15M | $16.43M |
| 1-day change | -8.48% | +2.14% |
| YTD return | -71.82% | -34.74% |
| 1-year return | -66.30% | -59.11% |
| 5-year return | — | -97.77% |
| EPS (TTM) | $-4.39 | $-0.82 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.45 | $2.45 |
| 52-week low | $0.177 | $0.489 |
| Distance from 52-week high | -80.43% | -73.07% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +541.52% | — |
| Average volume | 8.59M | 630.66K |
| Shares outstanding | 49.88M | 24.90M |
| Employees | 8 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About AEON Biopharma
AEON stock →AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine.
Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees
About Rocket One
RKTO stock →Rocket One Inc. focuses on developing and commercializing AI semiconductor infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
AEON vs RKTO FAQ
Which is bigger, AEON Biopharma or Rocket One?
Rocket One (RKTO) is larger, with a market capitalization of $16.43M compared with $14.15M for AEON Biopharma (AEON).
Which stock has performed better over the past year, AEON or RKTO?
RKTO returned -59.11% over the past 12 months, compared with -66.30% for AEON (price return, excluding dividends). Past performance does not predict future results.
Are AEON Biopharma and Rocket One in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.